Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Various functions of PBMC from colon cancer patients are not decreased compared to healthy blood donors.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskning

  1. Shelf-life of ɛ-lysyl-3-(trimethylstannyl)benzamide immunoconjugates, precursors for 211At labeling of antibodies

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Sequential radioimmunotherapy with 177Lu- and 211At-labeled monoclonal antibody BR96 in a syngeneic rat colon carcinoma model

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Comparison of (211)At-PRIT and (211)At-RIT of Ovarian Microtumors in a Nude Mouse Model

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Evaluation of effects on the peritoneum after intraperitoneal α-radioimmunotherapy with (211)At

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Intraperitoneal alpha-radioimmunotherapy in mice using different specific activities

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Genome-wide cell-free DNA fragmentation in patients with cancer

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  2. Triage for selection to colonoscopy?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Clean Colorectum at Diagnostic Colonoscopy: Subsequent Detection of Extracolonic Malignancies by Plasma Protein Biomarkers?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
The immune surveillance hypothesis suggests impaired immune responses to participate in development of cancer. This may partly be due to increased amounts of PGE2 and histamine, which inhibit cellular immunity. These effects are mediated by cAMP, which is increased and thereby may down-regulate IL-2 and its receptor proteins in T helper cells. The proliferative responses and IL-2 synthesis of PBMC have earlier been shown to be reduced in patients with colon cancer. Recently immune modulating agents have been demonstrated to increase the proliferative response of PBMC in vitro, probably by inhibition of adenylate cyclase activity and induction of IL-2 mRNA expression. We have therefore studied the proliferative responses of PBMC from colon cancer patients to PWM and tested the effect of immune modulating agents, such as Serotonin, Sumatriptan, and Buspirone on these PBMC. We found no difference in levels of intracellular cAMP, IL-2 mRNA expression, IL-2R mRNA expression, or proliferative responses of PBMC from colon cancer patients compared to healthy blood donors. There was no effect of the immune modulating agents on PBMC from colon cancer patients.
Bidragets oversatte titelVarious functions of PBMC from colon cancer patients are not decreased compared to healthy blood donors.
OriginalsprogEngelsk
TidsskriftCancer Biotherapy & Radiopharmaceuticals
Vol/bind12
Udgave nummer2
Sider (fra-til)73-78
Antal sider6
ISSN1084-9785
StatusUdgivet - 1997

ID: 32503690